AU2005210134B2 - Microemulsion formulations comprising particular substance P antagonists - Google Patents

Microemulsion formulations comprising particular substance P antagonists Download PDF

Info

Publication number
AU2005210134B2
AU2005210134B2 AU2005210134A AU2005210134A AU2005210134B2 AU 2005210134 B2 AU2005210134 B2 AU 2005210134B2 AU 2005210134 A AU2005210134 A AU 2005210134A AU 2005210134 A AU2005210134 A AU 2005210134A AU 2005210134 B2 AU2005210134 B2 AU 2005210134B2
Authority
AU
Australia
Prior art keywords
composition
acid
enoic acid
methyl
pent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2005210134A
Other languages
English (en)
Other versions
AU2005210134A1 (en
Inventor
Waltraud Bueb
Barbara Luckel
Isabel Ottinger
Thomas Reinhart
Angelika Ries
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2005210134A1 publication Critical patent/AU2005210134A1/en
Application granted granted Critical
Publication of AU2005210134B2 publication Critical patent/AU2005210134B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2005210134A 2004-02-06 2005-02-04 Microemulsion formulations comprising particular substance P antagonists Ceased AU2005210134B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0402679.5 2004-02-06
GBGB0402679.5A GB0402679D0 (en) 2004-02-06 2004-02-06 Organic compounds
PCT/EP2005/001166 WO2005074891A1 (en) 2004-02-06 2005-02-04 Microemulsion formulations comprising particular substance p antagonists

Publications (2)

Publication Number Publication Date
AU2005210134A1 AU2005210134A1 (en) 2005-08-18
AU2005210134B2 true AU2005210134B2 (en) 2008-05-22

Family

ID=31985813

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005210134A Ceased AU2005210134B2 (en) 2004-02-06 2005-02-04 Microemulsion formulations comprising particular substance P antagonists

Country Status (15)

Country Link
US (1) US20080254113A1 (https=)
EP (1) EP1715848B1 (https=)
JP (1) JP2007520521A (https=)
CN (1) CN1929817B (https=)
AT (1) ATE475409T1 (https=)
AU (1) AU2005210134B2 (https=)
BR (1) BRPI0507492A (https=)
CA (1) CA2553658A1 (https=)
DE (1) DE602005022558D1 (https=)
ES (1) ES2349647T3 (https=)
GB (1) GB0402679D0 (https=)
PL (1) PL1715848T3 (https=)
PT (1) PT1715848E (https=)
RU (1) RU2397759C2 (https=)
WO (1) WO2005074891A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1938804A1 (en) * 2006-12-22 2008-07-02 Novartis AG Pharmaceutical formulation comprising neurokinin antagonist
RU2481822C1 (ru) * 2012-02-21 2013-05-20 Автономная некоммерческая организация "Институт медико-биологических исследований и технологий" (АНО "ИМБИИТ") Микроэмульсионные композиции для создания трансдермальных и трансмукозальных форм фармацевтических средств и косметических препаратов и способ их получения
AU2014204739B2 (en) * 2013-01-14 2016-08-11 Infirst Healthcare Limited Compositions and methods for treating severe pain
EP3086777A1 (en) * 2013-12-23 2016-11-02 Johnson & Johnson Consumer Inc. Racecadotril compositions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319917B1 (en) * 1996-08-22 2001-11-20 Novartis Ag Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ502567A (en) * 1997-07-29 2002-03-28 Upjohn Co Self-emulsifying formulation for lipophilic compounds containing a pyranone and a mixture of monoglycerides and diglycerides
EP1107744B1 (en) * 1998-08-25 2003-04-23 Novartis AG Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
MY120392A (en) * 2000-06-08 2005-10-31 Hovid Berhad A novel drug delivery system : formulation for fat-soluble drugs

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319917B1 (en) * 1996-08-22 2001-11-20 Novartis Ag Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
American Pharmaceutical Review, 2002, vol. 5, no. 4, pp 22-8 *
Bioorganic & Medicinal Chemistry Letters, 2001, vol. 11, no. 23, pp 3081-4 *
Farmaceuticky Obzor, 2003, vol. 72, no. 4-5, pp 87-92 *

Also Published As

Publication number Publication date
GB0402679D0 (en) 2004-03-10
DE602005022558D1 (de) 2010-09-09
BRPI0507492A (pt) 2007-07-17
PL1715848T3 (pl) 2011-01-31
CN1929817B (zh) 2012-04-25
EP1715848A1 (en) 2006-11-02
ATE475409T1 (de) 2010-08-15
CN1929817A (zh) 2007-03-14
RU2397759C2 (ru) 2010-08-27
EP1715848B1 (en) 2010-07-28
AU2005210134A1 (en) 2005-08-18
CA2553658A1 (en) 2005-08-18
WO2005074891A1 (en) 2005-08-18
US20080254113A1 (en) 2008-10-16
ES2349647T3 (es) 2011-01-07
PT1715848E (pt) 2010-10-21
RU2006131788A (ru) 2008-03-20
JP2007520521A (ja) 2007-07-26

Similar Documents

Publication Publication Date Title
NO342592B1 (no) Farmasøytisk sammensetning som innbefatter et kamptotecinderivat, og fremgangsmåte for fremstilling derav.
US10188696B2 (en) Pharmaceutical compositions
AU2006222117B2 (en) Microemulsions of cannabinoid receptor binding compounds
AU2005210134B2 (en) Microemulsion formulations comprising particular substance P antagonists
MXPA06008856A (en) Microemulsion formulations comprising particular substance p antagonists
KR20070018003A (ko) 특정 물질 ｐ 길항제를 포함하는 마이크로에멀젼 제제
HK1186658B (en) Pharmaceutical compositions comprising alisporivir
HK1186658A (en) Pharmaceutical compositions comprising alisporivir

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired